Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.

Slovak ML, Gundacker H, Bloomfield CD, Dewald G, Appelbaum FR, Larson RA, Tallman MS, Bennett JM, Stirewalt DL, Meshinchi S, Willman CL, Ravindranath Y, Alonzo TA, Carroll AJ, Raimondi SC, Heerema NA.

Leukemia. 2006 Jul;20(7):1295-7. Epub 2006 Apr 20. No abstract available.

PMID:
16628187
2.

Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis.

Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T, Naoe T, Taniguchi S, Kawa K, Nagamura T, Atsuta Y, Sakamaki H.

Leukemia. 2012 Mar;26(3):461-4. doi: 10.1038/leu.2011.229. Epub 2011 Aug 26.

PMID:
21869835
3.

[Translocation t(6;9;8)(p23;q34;q22) in acute myeloid leukemia: Contribution of fluorescence in situ hybridization].

van den Akker J, Pérot C, Portnoï MF, Philizot L, Dupont JM, Laporte JP, Taillemite JL.

Ann Genet. 1995;38(3):168-71. French. Erratum in: Ann Genet 1995;38(4):230.

PMID:
8540689
4.
5.

A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.

Nguyen S, Leblanc T, Fenaux P, Witz F, Blaise D, Pigneux A, Thomas X, Rigal-Huguet F, Lioure B, Auvrignon A, Fière D, Reiffers J, Castaigne S, Leverger G, Harousseau JL, Socié G, Dombret H.

Blood. 2002 May 15;99(10):3517-23.

6.

The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases.

Gupta M, Ashok Kumar J, Sitaram U, Neeraj S, Nancy A, Balasubramanian P, Abraham A, Mathews V, Viswabandya A, George B, Chandy M, Srivastava A, Srivastava VM.

Cancer Genet Cytogenet. 2010 Dec;203(2):297-302. doi: 10.1016/j.cancergencyto.2010.08.012.

PMID:
21156248
7.

Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients.

Morschhauser F, Cayuela JM, Martini S, Baruchel A, Rousselot P, Socié G, Berthou P, Jouet JP, Straetmans N, Sigaux F, Fenaux P, Preudhomme C.

J Clin Oncol. 2000 Feb;18(4):788-94.

PMID:
10673520
8.

Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript.

Hamaguchi H, Nagata K, Yamamoto K, Fujikawa I, Kobayashi M, Eguchi M.

Br J Haematol. 1998 Sep;102(5):1249-56.

PMID:
9753053
9.

[A clinical and laboratory study on acute myeloid leukemia with t(6;9)(p23;q34)].

Wang Y, Xue Y, Chen S, Wu Y, Pan J, Zhang J, Shen J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Feb;27(1):34-7. doi: 10.3760/cma.j.issn.1003-9406.2010.01.007. Chinese.

PMID:
20140864
10.

[Analysis of DEK-CAN fusion gene expression in acute myeloid leukemia patients with 6; 9 chromosome translocation].

Wang YL, Wang T, Xu F, Gang Y, Wang J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):232-6. Chinese.

PMID:
16638187
12.

Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant.

Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T, Naoe T, Taniguchi S, Kawa K, Nagamura T, Tabuchi K, Atsuta Y, Sakamaki H.

Leukemia. 2012 Jun;26(6):1416-9. doi: 10.1038/leu.2011.350. Epub 2011 Dec 9. No abstract available.

PMID:
22157737
14.

The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.

Scholl C, Schlenk RF, Eiwen K, Döhner H, Fröhling S, Döhner K; AML Study Group.

Haematologica. 2005 Dec;90(12):1626-34.

15.

[Acute myeloblastic leukemia without maturation (AML-M1) with basophilic elements and associated with translocation t(6;9)].

Dimicoli S, Fohlen-Walter A, Mansuy L, Buisine J, Grégoire MJ, Lecompte T, Bordigoni P, Jonveaux P, Lesesve JF.

Ann Biol Clin (Paris). 2003 May-Jun;61(3):352-7. French.

PMID:
12805015
16.

Dek-can rearrangement in translocation (6;9)(p23;q34).

Soekarman D, von Lindern M, van der Plas DC, Selleri L, Bartram CR, Martiat P, Culligan D, Padua RA, Hasper-Voogt KP, Hagemeijer A, et al.

Leukemia. 1992 Jun;6(6):489-94.

PMID:
1602786
17.

Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.

Super HG, Strissel PL, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznik-Le NJ, Diaz MO, Rowley JD.

Genes Chromosomes Cancer. 1997 Oct;20(2):185-95.

PMID:
9331569
18.

Translocation (6;9)(p23;q34) in smoldering leukemia and acute nonlymphocytic leukemia.

Fonatsch C, Stollmann B, Holldack J, Engert A.

Cancer Genet Cytogenet. 1987 Jun;26(2):363-8.

PMID:
3567880
19.

Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.

Jourdan E, Dastugue N.

Cancer. 2005 Mar 15;103(6):1316; author reply 1316-7. Review. No abstract available.

20.

Chromosomal rearrangements with a common breakpoint at 6p23 in five cases of myeloid leukemia.

Fleischman EW, Prigogina EL, Iljinskaja GW, Konstantinova LN, Puchkova GP, Volkova MA, Frenkel MA, Balakirev SA.

Hum Genet. 1983;64(3):254-6.

PMID:
6576981
Items per page

Supplemental Content

Write to the Help Desk